SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities
SEC Accession No. 0000904454-12-000018
Filing Date
2012-01-17
Accepted
2012-01-17 21:40:38
Documents
1
Period of Report
2011-01-01
Filing Date Changed
2012-01-17

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgar.html 3  
1 PRIMARY DOCUMENT edgar.xml 3 2951
  Complete submission text file 0000904454-12-000018.txt   4306
Mailing Address 300 GEORGE STREET NEW HAVEN CT 06511
Business Address 300 GEORGE STREET NEW HAVEN CT 06511 203-624-7000
ACHILLION PHARMACEUTICALS INC (Issuer) CIK: 0001070336 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1

Mailing Address C/O DOMAIN ASSOCIATES, L.L.C. ONE PALMER SQUARE, SUITE 515 PRINCETON NJ 08542
Business Address
Kamdar Kim P. (Reporting) CIK: 0001535065 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-33095 | Film No.: 12530810